TD Asset Management »

Autolus Therapeutics Plc spon ads shares owned by TD Asset Management

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 342k 6.38
2023-12-31 $871k 135k 6.44
2019-12-31 $225k 17k 13.19
2019-09-30 $250k 20k 12.42
2019-06-30 $342k 21k 16.11
2019-03-31 $332k 11k 31.47
2018-12-31 $333k 10k 32.81
2018-09-30 $300k 9.9k 30.15
2018-06-30 $258k 9.6k 26.74

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Canadian Pacific Kansas City (CP)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Meta Platforms Cl A (META)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Enbridge (ENB)
Visa Com Cl A (V)
Broadcom (AVGO)

View all positions for TD Asset Management

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads